Ym Biosciences Reports Phase II Data for Nimotuzumab in Metastatic Colorectal Cancer
Red Orbit (Free subscription) | 05/08/2008
MISSISSAUGA, ON, Aug. 4 /PRNewswire-FirstCall/ -- YM BioSciences Inc.
- add comment
- send to a friend
- Explore : Mississauga
Ym Biosciences Inc
+Vote!
+Vote!
MBF Financial: *Revised* Analyst Reports for Rubicon Minerals Corporation, YM BioSciences Inc., Ableauctions.com Inc., and FieldPoint Petroleum Corporation
Market Wire - Investment Opinion (Free subscription) | 09/07/2008
LONDON (MARKET WIRE) MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Through our numerous partnerships with many of the top investment minds in the world, we provide research on companies making a move in the markets. Investors seeking genuine analyst opinions on their investments for Rubicon Minerals Corporation (AMEX: RBY), YM BioSciences Inc....
+Vote!
YM BIOSCIENCES ANNOUNCES FDA LIFTS CLINICAL HOLD ON AEROLEF(R) AND CLEARANCE OF A PHASE II ...
Life Science World (Free subscription) | 20/06/2008
[NEWS] - Dr. Ali Raza To Lead Further Development Of AeroLEF As President Of AeroLEF Division - MISSISSAUGA, ON, June 19 /PRNewswire-FirstCall/ - YM BioSciences Inc. (AMEX: YMI, TSX: YM, AIM: YMBA), an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today announced that the Clinical Hold imposed by the US Food and Drug Administration (FDA)...
- add comment
- send to a friend
- Explore : AIM, Biotechnologies, Mississauga
+Vote!
Ym Biosciences Announces Presentations for Aerolef(Tm) at American Pain Society Annual Meeting
Red Orbit (Free subscription) | 05/05/2008
MISSISSAUGA, ON, May 5 /PRNewswire-FirstCall/ -- YM BioSciences Inc.
- add comment
- send to a friend
- Explore : Biotechnologies, Mississauga
+Vote!
YM BIOSCIENCES ANNOUNCES PRESENTATIONS FOR AEROLEF(TM) AT AMERICAN PAIN SOCIETY ANNUAL MEETING
The Earth Times Online Newspaper (Free subscription) | 05/05/2008
MISSISSAUGA, ON, May 5 /PRNewswire-FirstCall/ -- YM BioSciences Inc. , an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today announce...
- add comment
- send to a friend
- Explore : Biotechnologies, Health-Fitness, Mississauga, Pain
+Vote!
Ym Biosciences Announces Presentations for Two of Its Anti-Cancer Drugs at Aacr Annual Meeting
Red Orbit (Free subscription) | 12/04/2008
MISSISSAUGA, ON, April 11 /PRNewswire-FirstCall/ -- YM BioSciences Inc.
- add comment
- send to a friend
- Explore : Mississauga
